BRPI0922701A8 - Método para intensificar atividade viral mediada por interferon em um animal de companhia - Google Patents

Método para intensificar atividade viral mediada por interferon em um animal de companhia

Info

Publication number
BRPI0922701A8
BRPI0922701A8 BRPI0922701A BRPI0922701A BRPI0922701A8 BR PI0922701 A8 BRPI0922701 A8 BR PI0922701A8 BR PI0922701 A BRPI0922701 A BR PI0922701A BR PI0922701 A BRPI0922701 A BR PI0922701A BR PI0922701 A8 BRPI0922701 A8 BR PI0922701A8
Authority
BR
Brazil
Prior art keywords
companion animal
viral activity
mediated viral
enhance interferon
interferon
Prior art date
Application number
BRPI0922701A
Other languages
English (en)
Inventor
Zicker Steven
Zebulon Frantz Nolan
A Brockman Jeffrey
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of BRPI0922701A2 publication Critical patent/BRPI0922701A2/pt
Publication of BRPI0922701A8 publication Critical patent/BRPI0922701A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

USO DE ÁCIDO LIPÓICO. A invenção encerra composições para intensificar a capacidade de um animal de companhia para resistir e/ou superar infecções virais. As composições da invenção incluem uma quantidade de ácido lipóico que seja eficaz em intensificar a imunidade antiviral de um animal de companhia.
BRPI0922701A 2008-12-16 2009-12-16 Método para intensificar atividade viral mediada por interferon em um animal de companhia BRPI0922701A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/336,024 US8592479B2 (en) 2000-10-31 2008-12-16 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
PCT/US2009/068166 WO2010077903A1 (en) 2008-12-16 2009-12-16 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals

Publications (2)

Publication Number Publication Date
BRPI0922701A2 BRPI0922701A2 (pt) 2015-08-04
BRPI0922701A8 true BRPI0922701A8 (pt) 2016-12-27

Family

ID=42025639

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922701A BRPI0922701A8 (pt) 2008-12-16 2009-12-16 Método para intensificar atividade viral mediada por interferon em um animal de companhia

Country Status (10)

Country Link
US (1) US8592479B2 (pt)
EP (1) EP2358216B1 (pt)
JP (1) JP5743903B2 (pt)
CN (1) CN102245033B (pt)
AU (1) AU2009333295B2 (pt)
BR (1) BRPI0922701A8 (pt)
CA (1) CA2744056C (pt)
RU (1) RU2485799C2 (pt)
WO (1) WO2010077903A1 (pt)
ZA (1) ZA201103884B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
RU2377980C2 (ru) * 2005-08-17 2010-01-10 Хилл`С Пет Ньютришн, Инк. Способы и композиции для профилактики и лечения заболеваний почек
DK2367549T3 (da) 2008-12-30 2013-11-04 Hills Pet Nutrition Inc Anvendelse af alfalipoinsyre til behandling eller forebyggelse af nedbrydende ledsygdomme, osteoarthritis, bruskskade, og relaterede lidelser hos kæledyr
CA2750192C (en) * 2008-12-30 2016-11-08 Hill's Pet Nutrition, Inc. Methods for increasing the palatability of companion animal food compositions
JP2014532032A (ja) * 2011-04-05 2014-12-04 ロンザ・リミテッド 疲労を減少させるためまたは予防するためおよび認知機能を改善するためのｌ−カルニチン、その塩および誘導体の使用
EP2508179A1 (en) * 2011-04-05 2012-10-10 Lonza Ltd. Use of L-Carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
CN102657297A (zh) * 2012-05-30 2012-09-12 扬州大学 一种调控高产奶牛围产期氧化应激的方法
CN106668031A (zh) * 2015-11-05 2017-05-17 北京蔚蓝之源医药科技有限公司 生育三烯酚衍生物的用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006361A (en) * 1980-10-03 1991-04-09 Cox James P Lipid pelletization methods, apparatus and products
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
US5030458A (en) 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
PT95826B (pt) 1989-11-09 1997-11-28 Asta Medica Ag Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
ZA965149B (en) 1996-06-18 1997-01-23 Henry John Davis Vitamin and nutrient supplement compositions
US5937790A (en) * 1996-12-18 1999-08-17 Showa Denko Kabushiki Kaisha Anti-stress agent for animals and a method of reducing stress in animals
US6080788A (en) 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
DE69814834T2 (de) 1997-03-27 2004-04-08 Sole, Michael J., Toronto Ernährungszusammensetzung zur verbesserung der zellenenergie
US6232346B1 (en) 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
US5883083A (en) 1997-06-09 1999-03-16 Harlmen, Inc. Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
NZ527924A (en) 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
CA2285490C (en) 1999-10-07 2003-11-18 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
CA2389623A1 (en) 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
DE60018545T2 (de) 2000-01-20 2006-04-06 Innovet Italia S.R.L. Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
EP1250052A1 (en) 2000-01-25 2002-10-23 Juvenon, Inc. Nutritional supplements for aged pets
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
DE10340845A1 (de) * 2003-09-04 2005-03-31 Flavin-Koenig, Dana F., Dr. Pharmazeutisches Kombinationspräparat, enthaltend Glycyrrhizinsäure, Zink und eine Verbindung, die eine Thiolgruppe oder eine zu dieser metabolisierbare Gruppe enthält
US7078064B2 (en) * 2003-12-03 2006-07-18 George Zabrecky Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
CN101106984B (zh) * 2004-11-24 2012-10-24 希尔氏宠物营养品公司 包含硫辛酸的组合物及其用途
US8168161B2 (en) 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
AU2005322887B2 (en) 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
NL2000008C2 (nl) 2006-02-16 2007-08-17 Apo Pharmaceuticals Internat B Samenstelling en doseereenheid als voedingssupplement en voor de behandeling van retinis pigmentosa.
US20070292535A1 (en) 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions

Also Published As

Publication number Publication date
US20090149529A1 (en) 2009-06-11
CA2744056A1 (en) 2010-07-08
BRPI0922701A2 (pt) 2015-08-04
JP5743903B2 (ja) 2015-07-01
WO2010077903A1 (en) 2010-07-08
CN102245033A (zh) 2011-11-16
RU2485799C2 (ru) 2013-06-27
AU2009333295B2 (en) 2013-01-10
EP2358216B1 (en) 2016-10-12
CA2744056C (en) 2014-03-25
US8592479B2 (en) 2013-11-26
JP2012511932A (ja) 2012-05-31
CN102245033B (zh) 2015-02-04
RU2011129617A (ru) 2013-01-27
EP2358216A1 (en) 2011-08-24
AU2009333295A1 (en) 2011-06-23
ZA201103884B (en) 2016-10-26

Similar Documents

Publication Publication Date Title
BR112014011162A2 (pt) derivados purínicos para o tratamento de infecções virais
BR112013027670A2 (pt) "composto de amida, composição farmacêutica e medicamento que o compreende e antagonista de rory"
BR112015000615A2 (pt) purinas macrocíclicas para o tratamento de infecções virais
BR112012009214A2 (pt) compostos
BR112013006038A2 (pt) adesivos de soja e compostos feitos de adesivos.
BR112015022782A2 (pt) composto, composição farmacêutica, combinação, e, uso de um composto
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
BR112015027315A2 (pt) melhorias nos ou relativas aos compostos orgânicos
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
BR112014029781A2 (pt) soluções de tensoativos contendo n-metil-n-c8-c10-acilglucaminas e n-metil-n-c12-c14-acilglucaminas
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
ATE550023T1 (de) Stabile feste zubereitung mit 4,5- epoxymorphinanderivat
EP2156339A4 (en) DISCOSQL: DISTRIBUTED PROCESSING OF STRUCTURED QUESTIONS
BRPI0514766A (pt) composições farmacêuticas
GT201400027A (es) Acuosa suspensión concentrada que comprende un ácido sal de dodecilguanidina
ECSP11011101A (es) Compuestos cicloundecadepsipéptidos y el uso de dichos compuestos como un medicamento
CY1111652T1 (el) Αντιμικροβiακη συνθεση
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
UY29416A1 (es) Derivados de ácido pirimidincarboxílico y su uso
BR112016001779A2 (pt) comprimido em bicamada, e, processo
BR112012020674A2 (pt) artigo depilatório aquoso e flexível
ECSP088574A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
BR112015005876A2 (pt) partículas derivadas de ácido propiônico com baixo ponto de fusão para uso em formas de dosagem oral
BR112014030287A2 (pt) composição farmacêutica
BRPI0923454A2 (pt) "métodos para intensificar uma capacidade de um animal de estimação resistir ou combater uma infecção viral e para tratar uma infecção viral em um animal de estimação.

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A23K 1/18 , A61K 31/385 , A23K 1/16

Ipc: A23K 20/121 (2016.01), A61K 31/385 (2006.01), A23K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2545 DE 15-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.